Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept

This publication has 13 references indexed in Scilit:

• Teicoplanin and therapeutic drug monitoring: An update for optimal use in different patient populations
  Journal of Infection and Chemotherapy, 2020
• Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
  Intensive Care Medicine, 2020
• Osteoarticular infections: a specific program for older patients?
  Aging Clinical and Experimental Research, 2019
• Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
  Open Forum Infectious Diseases, 2018
• Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011–2016)
  International Journal of Antimicrobial Agents, 2018
• Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target
  Antimicrobial Agents and Chemotherapy, 2015
• Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
  Clinical Microbiology Reviews, 2015
• Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
  Antimicrobial Agents and Chemotherapy, 2015
• New Lipoglycopeptides
  Drugs, 2010
• Penetration of Antibacterials into Bone
  Clinical Pharmacokinetics, 2009